Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
British Journal of Cancer
|
January 1, 1997
Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069
A V Patterson, M P Saunders, E C Chinje, et al.
British Journal of Cancer
|
September 29, 2004
Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer
M P Saunders, M Hogg, B Carrington, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 21, 2006
Preoperative radiotherapy for operable rectal cancer--is a lower dose to a reduced volume acceptable?
M P Saunders, H Alderson, A Chittalia, et al.
British Journal of Cancer
|
January 11, 2007
Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study
H Y Sheikh, J W Valle, K Palmer, et al.
British Journal of Cancer
|
October 13, 2006
A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei
R Bibi, N Pranesh, M P Saunders, et al.
Radiology
|
February 1, 1997
Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement
A Adam, J Ellul, A F Watkinson, et al.
Diseases of the Colon and Rectum
|
December 8, 2009
Treatments and outcomes of peritoneal surface tumors through a centralized national service (United kingdom)
S Rout, A G Renehan, M F Parkinson, et al.
British Journal of Cancer
|
July 31, 2003
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy
S E Duff, C Li, M Jeziorska, et al.
Abdominal Imaging
|
October 29, 2003
Use of the Bard Memotherm self-expanding metal stent in the palliation of colonic obstruction
J S Clark, G N Buchanan, A R Khawaja, et al.
British Journal of Cancer
|
August 7, 2008
Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer
H Y Sheikh, J W Valle, T Waddell, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
British Journal of Cancer
|
January 1, 1997
Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069
A V Patterson, M P Saunders, E C Chinje, et al.
British Journal of Cancer
|
September 29, 2004
Phase I dose-escalation trial of irinotecan with continuous infusion 5-FU first line, in metastatic colorectal cancer
M P Saunders, M Hogg, B Carrington, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
October 21, 2006
Preoperative radiotherapy for operable rectal cancer--is a lower dose to a reduced volume acceptable?
M P Saunders, H Alderson, A Chittalia, et al.
British Journal of Cancer
|
January 11, 2007
Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study
H Y Sheikh, J W Valle, K Palmer, et al.
British Journal of Cancer
|
October 13, 2006
A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei
R Bibi, N Pranesh, M P Saunders, et al.
Radiology
|
February 1, 1997
Palliation of inoperable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement
A Adam, J Ellul, A F Watkinson, et al.
Diseases of the Colon and Rectum
|
December 8, 2009
Treatments and outcomes of peritoneal surface tumors through a centralized national service (United kingdom)
S Rout, A G Renehan, M F Parkinson, et al.
British Journal of Cancer
|
July 31, 2003
Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy
S E Duff, C Li, M Jeziorska, et al.
Abdominal Imaging
|
October 29, 2003
Use of the Bard Memotherm self-expanding metal stent in the palliation of colonic obstruction
J S Clark, G N Buchanan, A R Khawaja, et al.
British Journal of Cancer
|
August 7, 2008
Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer
H Y Sheikh, J W Valle, T Waddell, et al.
Page
of 6